Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Go back to Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Quest Diagnostics (NYSE: DGX) Delayed: 235.50 --0 (-0%)
Previous Close $235.50    52 Week High $86.85 
Open $235.50    52 Week Low $59.66 
Day High $235.50    P/E 44.35 
Day Low $235.50    EPS $5.31 
Volume 910